Discover 3,591 paid clinical trials in Fullerton, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,591
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
Location: Los Angeles CA, San Francisco CA, San Antonio TX,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06413680
Phase 1, Phase 2, Recruiting
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
Location: Los Angeles CA, Santa Barbara CA, Scottsdale AZ,
Sponsor: Artios Pharma Ltd
Sex: All
Age: 18+
Code: NCT04657068
Phase 1, Phase 2, Recruiting
Breast Cancer Survivorship Biorepository
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: Female
Age: 18+
Code: NCT05786664
Recruiting
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
for
Advanced Solid Tumor, Unresectable Solid Tumor,
Location: Los Angeles CA, Scottsdale AZ, San Francisco CA,
Sponsor: Clasp Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06778863
Phase 1, Recruiting
Manual Lymphatic Drainage Breast Massage in Breast Cancer Patients After Breast Conserving Surgery
for
Anatomic Stage 0 Breast Cancer AJCC v8,
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: Female
Age: 18+
Code: NCT06297265
Recruiting
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
for
Advanced Melanoma
Location: Los Angeles CA, Santa Monica CA, La Jolla CA, Tucson AZ,
Sponsor: Immunocore Ltd
Sex: All
Age: 18+
Code: NCT06112314
Phase 3, Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.
for
High-grade Serous Ovarian Carcinoma (HGSOC),
Location: Los Angeles CA, Vancouver, Toronto, Hackensack NJ,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06476808
Phase 1, Recruiting
Access to Genetic Testing in Underserved Patients With Cancer
for
Breast Carcinoma, Male Breast Carcinoma,
Location: Los Angeles CA, Rochester NY
Sponsor: University of Southern California
Sex: All
Age: 18+
Code: NCT06422455
Recruiting
A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC
for
Extensive-stage Small-cell Lung Cancer
Location: Los Angeles CA, Lexington KY, Atlanta GA, Rock Hill SC,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07459634
Phase 2, Recruiting
Using Indoor Air Filtration to Slow Atherothrombosis Progression in Adults With Ischemic Heart Disease History
for
Air Pollution, Atherosclerosis
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 65 - 70+
Code: NCT05867381
Recruiting
A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.
for
Advanced Solid Tumors Cancer, MSI-H Cancer
Location: Los Angeles CA, Chicago IL, Louisville KY, Maumee OH,
Sponsor: Nimbus Wadjet, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06898450
Phase 1, Phase 2, Recruiting
Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation
for
Severe Tricuspid Regurgitation
Location: Thousand Oaks CA, Phoenix AZ, Minneapolis MN,
Sponsor: Medtronic Cardiovascular
Sex: All
Age: 18+
Code: NCT07321899
Recruiting
An Integrative Multi-Omic Characterization of Head and Neck Carcinogenesis, Progression and Recurrence
for
Head and Neck Carcinoma
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 18+
Code: NCT06420219
Recruiting
A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors
for
Triple Negative Locally Advanced Non-resectable Breast Cancer,
Location: Los Angeles CA, Vancouver, San Antonio TX, Nashville TN,